A role of GABA analogues in the treatment of neurological diseases.
about
Binding interaction of a gamma-aminobutyric acid derivative with serum albumin: an insight by fluorescence and molecular modeling analysisThe GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.Basic Concepts in Understanding Recovery of Function in Vestibular Reflex Networks during Vestibular Compensation.Plasticity of spontaneous excitatory and inhibitory synaptic activity in morphologically defined vestibular nuclei neurons during early vestibular compensation.Effect of Γ-aminobutyric acid on kidney injury induced by renal ischemia-reperfusion in male and female rats: Gender-related differenceGABA transporters as targets for new drugs.GABAergic neuronal precursor grafting: implications in brain regeneration and plasticity.Mechanism of action of vigabatrin: correcting misperceptions.In Vivo Detection of CPP-115 Target Engagement in Human Brain.Synthesis of ring-substituted N-benzyl γ-phenyl GABA derivatives via reductive amination.Conformationally Restricted GABA with Bicyclo[3.1.0]hexane Backbone as the First Highly Selective BGT-1 Inhibitor.Stereochemical Control of Enzymatic Carbon-Carbon Bond-Forming Michael-Type Additions by "Substrate Engineering".Rapid and reliable quantitation of amino acids and myo-inositol in mouse brain by high performance liquid chromatography and tandem mass spectrometry.A new enantioselective synthesis of the anticonvulsant drug pregabalin (Lyrica) based on a hydrolytic kinetic resolution method.Peptide-catalyzed stereoselective conjugate addition reactions generating all-carbon quaternary stereogenic centers.Role of GABAergic activity of sodium valproate against ischemia-reperfusion-induced acute kidney injury in rats.Neuroprotective potential of astroglia.Asymmetric Conjugate Addition of α,α-Disubstituted Aldehydes to Nitroalkenes Organocatalyzed by Chiral Monosalicylamides from trans-Cyclohexane-1,2-Diamines.Visible-Light-Mediated Decarboxylative Radical Additions to Vinyl Boronic Esters: Rapid Access to γ-Amino Boronic Esters.Development of an (S)-1-{2-[Tris(4-methoxyphenyl)methoxy]ethyl}piperidine-3-carboxylic acid [(S)-SNAP-5114] Carba Analogue Inhibitor for Murine γ-Aminobutyric Acid Transporter Type 4
P2860
Q27318662-D6EE9BDD-A110-45DE-8C2C-A5093FE578F0Q30461456-5FF0667A-0BF2-43F4-924B-6702C9E5ED67Q30470282-E96C314E-7F64-42A3-BCA0-F4B56D2F6320Q35951345-3005C51C-8231-4E2A-9CCC-B6E8FC9C04F4Q35999568-3B98DDCA-3DD6-4584-9DA8-82C8D58EEAD7Q37856289-1E62C8E4-E780-4F65-86F6-390BCC0B60C3Q37902082-D300E405-E1BC-4917-A207-0DB0E7B997B2Q37953574-9968A2D9-68AB-428E-900D-4F4C2AF0F6E0Q38662848-C0B693A7-3BB3-412E-BCF2-8EBF0FA7838EQ39768845-0E390FE4-941D-4FE2-A282-B0D22E12DDC5Q41817527-CA22B6BE-EA17-4059-967C-4478227F28E5Q42366816-29E040DF-BE16-44DC-B182-22BC46EDC752Q42552773-8635A9FD-AD0F-43F1-B127-B282658CFCCDQ44011443-56FB1968-4293-4790-9FF3-6121FDBB0313Q44099692-F6DF9ADD-5F84-4CFD-B492-A47DC1D7D43BQ46958159-732C6301-E093-44EB-9060-03B7F2611B76Q47916378-3730B5C3-F199-4FF6-9284-8C36308ACBF8Q48260191-F1BFCA90-78EE-4DBD-9D3E-D9D9502D2596Q48280572-7ED13473-8769-4068-8943-9C59EF25112AQ59157179-A192E2DA-3119-4DAF-9A04-07AF5B494A3C
P2860
A role of GABA analogues in the treatment of neurological diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A role of GABA analogues in the treatment of neurological diseases.
@en
A role of GABA analogues in the treatment of neurological diseases.
@nl
type
label
A role of GABA analogues in the treatment of neurological diseases.
@en
A role of GABA analogues in the treatment of neurological diseases.
@nl
prefLabel
A role of GABA analogues in the treatment of neurological diseases.
@en
A role of GABA analogues in the treatment of neurological diseases.
@nl
P2093
P1476
A role of GABA analogues in the treatment of neurological diseases.
@en
P2093
P304
P356
10.2174/092986710791698549
P577
2010-01-01T00:00:00Z